SCL Science Inc. (KOSDAQ:246960)
2,175.00
-25.00 (-1.14%)
At close: Apr 2, 2026
SCL Science Revenue
In the year 2025, SCL Science had annual revenue of 22.01B KRW with 364.64% growth. SCL Science had revenue of 8.29B in the quarter ending December 31, 2025, with 219.03% growth.
Revenue
22.01B
Revenue Growth
+364.64%
P/S Ratio
3.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
73.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.01B | 17.27B | 364.64% |
| Dec 31, 2024 | 4.74B | 3.42B | 258.30% |
| Dec 31, 2023 | 1.32B | 952.33M | 257.54% |
| Dec 31, 2022 | 369.78M | -137.51M | -27.11% |
| Dec 31, 2021 | 507.29M | -88.90M | -14.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 135.41B |
| JW Shinyak | 81.04B |
| Sewoon Medical | 63.66B |
| CG MedTech | 47.23B |
| OSTEONIC | 45.39B |
| DuChemBIO | 38.57B |
| Wonbiogen | 35.24B |
| Billions | 25.31B |